FOR PLUS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FOR PLUS PHARMA
Largest movements
- Receivables within one year +€115,297
up €115,297 (+52.8%), from €218,269 to €333,566
of which Trade receivables: +€130,820
- Tangible fixed assets +€21,609
up €21,609 (+329.7%), from €6,554 to €28,163
- Profit (loss) carried forward +€82,647
up €82,647 (+679.5%), from €12,162 to €94,809
- Trade debts +€59,764
up €59,764 (+270.4%), from €22,099 to €81,863
- Tax, wage and social debts -€53,228
down €53,228 (-68.7%), from €77,432 to €24,204
of which Taxes: -€37,568
- Other debts +€43,394
up €43,394 (+110.0%), from €39,446 to €82,840
- Advances received +€5,000
up €5,000 (+5.5%), from €91,735 to €96,735
- Gross operating margin +€78,836
up €78,836 (+403.4%), from €19,543 to €98,379
- Financial charges +€4,526
up €4,526 (+346.7%), from €1,305 to €5,831
of which Financial charges: +€3,443
- Taxes +€3,305
up €3,305 (+5572.6%), from €59 to €3,364
- Other operating charges -€2,069
down €2,069 (-56.9%), from €3,638 to €1,569
- Depreciation +€1,628
up €1,628 (+48.8%), from €3,340 to €4,968
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €247,875 | €385,451 | +€137,577 | +55.5% |
| Fixed assets | 21/28 | €6,631 | €28,298 | +€21,667 | +326.8% |
| Intangible fixed assets | 21 | €77 | - | -€77 | |
| Tangible fixed assets | 22/27 | €6,554 | €28,163 | +€21,609 | +329.7% |
| Furniture and vehicles | 24 | €6,554 | €28,163 | +€21,609 | +329.7% |
| Financial fixed assets | 28 | - | €135 | +€135 | |
| Current assets | 29/58 | €241,244 | €357,153 | +€115,910 | +48.0% |
| Stocks and contracts in progress | 3 | €19,500 | €19,500 | = | 0.0% |
| Stocks | 30/36 | €19,500 | €19,500 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €218,269 | €333,566 | +€115,297 | +52.8% |
| Trade receivables | 40 | €174,901 | €305,721 | +€130,820 | +74.8% |
| Other amounts receivable | 41 | €43,368 | €27,845 | -€15,523 | -35.8% |
| Cash at bank and in hand | 54/58 | - | €1,649 | +€1,649 | |
| Deferred charges and accrued income | 490/1 | €3,475 | €2,439 | -€1,036 | -29.8% |
| Total equity and liabilities | 10/49 | €247,875 | €385,451 | +€137,577 | +55.5% |
| Equity | 10/15 | €17,162 | €99,809 | +€82,647 | +481.6% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €12,162 | €94,809 | +€82,647 | +679.5% |
| Amounts payable | 17/49 | €230,713 | €285,642 | +€54,930 | +23.8% |
| Amounts payable within one year | 42/48 | €230,713 | €285,642 | +€54,930 | +23.8% |
| Trade debts | 44 | €22,099 | €81,863 | +€59,764 | +270.4% |
| Suppliers | 440/4 | €22,099 | €81,863 | +€59,764 | +270.4% |
| Advances received on contracts in progress | 46 | €91,735 | €96,735 | +€5,000 | +5.5% |
| Taxes, remuneration and social security | 45 | €77,432 | €24,204 | -€53,228 | -68.7% |
| Taxes | 450/3 | €44,032 | €6,464 | -€37,568 | -85.3% |
| Remuneration and social security | 454/9 | €33,400 | €17,740 | -€15,660 | -46.9% |
| Other amounts payable | 47/48 | €39,446 | €82,840 | +€43,394 | +110.0% |
| Non-recurring operating income | 76A | - | €9,700 | +€9,700 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,340 | €4,968 | +€1,628 | +48.8% |
| Other operating charges | 640/8 | €3,638 | €1,569 | -€2,069 | -56.9% |
| Non-recurring operating charges | 66A | €10,000 | - | -€10,000 | |
| Gross operating margin | 9900 | €19,543 | €98,379 | +€78,836 | +403.4% |
| Operating profit (loss) | 9901 | €2,565 | €91,842 | +€89,277 | +3480.9% |
| Financial charges | 65/66B | €1,305 | €5,831 | +€4,526 | +346.7% |
| Recurring financial charges | 65 | €1,084 | €4,528 | +€3,443 | +317.5% |
| Non-recurring financial charges | 66B | €221 | €1,303 | +€1,082 | +489.7% |
| Profit (loss) for the period before taxes | 9903 | €1,259 | €86,011 | +€84,751 | +6729.6% |
| Income taxes | 67/77 | €59 | €3,364 | +€3,305 | +5572.6% |
| Profit (loss) for the period | 9904 | €1,200 | €82,647 | +€81,447 | +6786.8% |
| Profit (loss) for the period to be appropriated | 9905 | €1,200 | €82,647 | +€81,447 | +6786.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.